TBCRC 006: A multicenter phase II study of neoadjuvant lapatinib and trastuzumab in patients with HER2-overexpressing breast cancer. Background: Extinction of HER2 signaling in HER2 driven BC may be ...
Correlation coefficients range from -1 to +1, indicating the strength of relationships between variables. Investors use correlation coefficients for portfolio diversification to reduce risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback